1. Home
  2. ATXS vs BGS Comparison

ATXS vs BGS Comparison

Compare ATXS & BGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • BGS
  • Stock Information
  • Founded
  • ATXS 2008
  • BGS 1996
  • Country
  • ATXS United States
  • BGS United States
  • Employees
  • ATXS N/A
  • BGS N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • BGS Packaged Foods
  • Sector
  • ATXS Health Care
  • BGS Consumer Staples
  • Exchange
  • ATXS Nasdaq
  • BGS Nasdaq
  • Market Cap
  • ATXS 401.2M
  • BGS 354.3M
  • IPO Year
  • ATXS 2015
  • BGS N/A
  • Fundamental
  • Price
  • ATXS $6.85
  • BGS $4.21
  • Analyst Decision
  • ATXS Buy
  • BGS Hold
  • Analyst Count
  • ATXS 6
  • BGS 5
  • Target Price
  • ATXS $32.00
  • BGS $6.10
  • AVG Volume (30 Days)
  • ATXS 248.4K
  • BGS 2.8M
  • Earning Date
  • ATXS 08-12-2025
  • BGS 08-04-2025
  • Dividend Yield
  • ATXS N/A
  • BGS 18.05%
  • EPS Growth
  • ATXS N/A
  • BGS N/A
  • EPS
  • ATXS N/A
  • BGS N/A
  • Revenue
  • ATXS N/A
  • BGS $1,862,468,000.00
  • Revenue This Year
  • ATXS N/A
  • BGS N/A
  • Revenue Next Year
  • ATXS N/A
  • BGS $0.27
  • P/E Ratio
  • ATXS N/A
  • BGS N/A
  • Revenue Growth
  • ATXS N/A
  • BGS N/A
  • 52 Week Low
  • ATXS $3.56
  • BGS $3.67
  • 52 Week High
  • ATXS $12.92
  • BGS $9.44
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 56.47
  • BGS 49.37
  • Support Level
  • ATXS $6.60
  • BGS $3.98
  • Resistance Level
  • ATXS $7.20
  • BGS $4.38
  • Average True Range (ATR)
  • ATXS 0.47
  • BGS 0.18
  • MACD
  • ATXS -0.03
  • BGS 0.02
  • Stochastic Oscillator
  • ATXS 61.72
  • BGS 76.06

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About BGS B&G Foods Inc.

B&G Foods Inc is an American packaged-food manufacturer. It operate in a single industry segment and manufacture, sell and distribute a diverse portfolio of high-quality shelf-stable and frozen foods across the United States, Canada and Puerto Rico. Its products include frozen and canned vegetables, vegetable, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, The company's main brands are Ac'cent, B&G, B&M, Baker's Joy, Bear Creek Country Kitchens, Cary's, Cream of Rice, Cream of Wheat, Devonsheer, Don Pepino, Durkee, Emeril's, Grandma's Molasses, MacDonald's.

Share on Social Networks: